Projects per year
Abstract
In this study, nanofibrous scaffolds were used for in situ transfection application. Polyethylenimine (PEI)/DNA complexes adsorbed to alginate nanofibers, so the more alginate fibers resulted in the higher transfection efficiency. However, alginate was not favorable for cell adhesion. Therefore, poly (ε‑caprolactone) (PCL) nanofibers were electrospun with alginate to improve biocompatibility. The in situ transfection results demonstrated that although the incorporated PCL fibers effectively improved cell morphology, the bioactivity and proliferation rates of surface cells were not significantly increased due to the high ratio of alginate fibers. However, the reduction of the alginate ratio may decrease transfection efficiency because the immobilization of nonviral vectors linearly depended on the density of alginate fibers. To maintain transfection efficiency and increase biocompatibility, the stability of alginate fibers were manipulated by adjusting the concentrations of calcium ions during crosslinking. These partially crosslinked alginate fibers were initially intact to allow nanoparticle adsorption for cell uptake, and then gradually degraded in days to create an appropriate environment for cell survival. This dynamic system successfully fulfilled the requirements of both gene delivery and biocompatibility. To our knowledge, this study may be the first one which dynamically regulates scaffold composition for substrate-mediated gene delivery.
Original language | English |
---|---|
Pages (from-to) | 1169-1178 |
Number of pages | 10 |
Journal | International Journal of Biological Macromolecules |
Volume | 117 |
DOIs | |
State | Published - 1 Oct 2018 |
Keywords
- Alginate
- Co-electrospinning
- Composite nanofibers
- Degradation
- In situ transfection
Fingerprint
Dive into the research topics of 'The control of alginate degradation to dynamically manipulate scaffold composition for in situ transfection application'. Together they form a unique fingerprint.Projects
- 1 Finished
-
The Development of Indolicidin-Based Carrier to Deliver Antisense Oligonucleotide against Tnf-Α for the Treatment of Rheumatoid Arthritis
Hu, W.-W. (PI)
1/08/17 → 31/07/18
Project: Research